Want to join the conversation?
$OKE's partnership EBITDA contribution continues to increase sequentially as anticipated. The company expects EBITDA to be higher in 4Q15 and to be within the financial EBITDA guidance range for the year. The partnership's 3Q15 EBITDA of just over $400MM increased 4% vs. 3Q14 despite a nearly 67% drop in NGL prices.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?